CDCTB. World TB Day History. Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/tb/worldtbday/history.htm.
Tuberculosis (TB). https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
Baykan AH, et al. Extrapulmonary tuberculosıs: an old but resurgent problem. Insights Imaging. 2022;13:39.
PubMed PubMed Central Google Scholar
Kurihara M, et al. The challenge of differentiating tuberculous meningitis from bacterial meningitis. Respirol Case Rep. 2022;10(3):e0910. https://doi.org/10.1002/rcr2.910.
Mezochow A, Thakur K, Vinnard C. Tuberculous meningitis in children and adults: New insights for an ancient foe. Curr Neurol Neurosci Rep. 2017;17(11):85. https://doi.org/10.1007/s11910-017-0796-0. This review gives a useful overview of TBM including diagnostics and treatment up to ~2016.
Article PubMed PubMed Central Google Scholar
Sharma S, et al. Cytokines do play a role in pathogenesis of tuberculous meningitis: a prospective study from a tertiary care center in India. J Neurol Sci. 2017;379:131–6.
Soria J, Metcalf T, Mori N, Newby RE, Montano SM, Huaroto L, Ticona E, Zunt JR. Mortality in hospitalized patients with tuberculous meningitis. BMC Infect Dis. 2019;19(1):9. https://doi.org/10.1186/s12879-018-3633-4. Retrospective Peruvian TBM patient data is used in this publication. These data emphasize the importance of early HIV diagnosis in patients with suspected TBM.
Article PubMed PubMed Central Google Scholar
Soria J, Chiappe A, Gallardo J, Zunt JR, Lescano AG. Tuberculous meningitis: impact of timing of treatment initiation on mortality. Open Forum Infect Dis. 2021;8:345.
Chin JH. Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014;4(3):199–205. https://doi.org/10.1212/CPJ.0000000000000023. This brief review has good descriptions about TBM diagnostic challenges.
Article PubMed PubMed Central Google Scholar
Ssebambulidde K, Gakuru J, Ellis J, Cresswell FV, Bahr NC. Improving technology to diagnose tuberculous meningitis: Are we there yet? Front Neurol. 2022;30(13):892224. https://doi.org/10.3389/fneur.2022.892224. TBM diagnostic methods are captured elegantly in this very useful review. Detailed overviews of novel diagnostic technologies for TBM are also presented.
Cresswell FV, et al. Tuberculous meningitis international research consortium. Recent developments in tuberculous meningitis pathogenesis and diagnostics. Wellcome Open Res. 2021;4:164. https://doi.org/10.12688/wellcomeopenres.15506.3. This is an excellent up-to-date review focused on TBM pathogenesis. Novel diagnostic technologies are also discussed.
Arshad A, et al. Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment. J Clin Med. 2020;9(9):2962. https://doi.org/10.3390/jcm9092962. This review describes immune responses, pathogenesis, diagnosis and treatment of TBM. Table 1 in this review is a useful article list with descriptive summaries.
Manyelo CM, Solomons RS, Walzl G, Chegou NN. Tuberculous meningitis: pathogenesis, immune responses, diagnostic challenges, and the potential of biomarker-based approaches. J Clin Microbiol. 2021;59:e01771-e1820.
CAS PubMed PubMed Central Google Scholar
Jessen NA, Munk ASF, Lundgaard I, Nedergaard M. The glymphatic system: a beginner’s guide. Neurochem Res. 2015;40:2583–99.
CAS PubMed PubMed Central Google Scholar
Ben-Shaanan TL, et al. Modulation of anti-tumor immunity by the brain’s reward system. Nat Commun. 2018;9:2723.
PubMed PubMed Central Google Scholar
Caldwell LJ, Subramaniam S, MacKenzie G, Shah DK. Maximising the potential of neuroimmunology. Brain Behav Immun. 2020;87:189–92.
PubMed PubMed Central Google Scholar
Morimoto K, Nakajima K. Role of the immune system in the development of the central nervous system. Front Neurosci. 2019;13:916.
PubMed PubMed Central Google Scholar
Lee SH. Tuberculosis Infection and Latent Tuberculosis. Tuberc Respir Dis (Seoul). 2016;79(4):201–6. https://doi.org/10.4046/trd.2016.79.4.201. This review discusses factors that influence the transition from latent TB to active TB and emphasizes the importance of generating more latent TB treatments in groups defined in the paper to reduce overall TB burden.
Domingo-Gonzalez R, Prince O, Cooper A, Khader SA. Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiol Spectr. 2016;4(5). https://doi.org/10.1128/microbiolspec.TBTB2-0018-2016.
Arranz-Trullén J, Lu L, Pulido D, Bhakta S, Boix E. Host antimicrobial peptides: the promise of new treatment strategies against tuberculosis. Front Immunol. 2017;8:1499.
PubMed PubMed Central Google Scholar
Queval CJ, et al. Mycobacterium tuberculosis controls phagosomal acidification by targeting CISH-mediated signaling. Cell Rep. 2017;20:3188–98.
CAS PubMed PubMed Central Google Scholar
Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–66.
Pagán AJ, Ramakrishnan L. The Formation and Function of Granulomas. Annu Rev Immunol. 2018;26(36):639–65. https://doi.org/10.1146/annurev-immunol-032712-100022. This review does a great job defining granuloma formation and function.
Sugawara I, Yamada H, Mizuno S. Relative importance of STAT4 in murine tuberculosis. J Med Microbiol. 2003;52:29–34.
Flynn JL, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2(6):561–72. https://doi.org/10.1016/1074-7613(95)90001-2.
Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol Baltim Md. 1998;1950(161):2636–41.
Jain SK, Tobin DM, Tucker EW, Venketaraman V, Ordonez AA, Jayashankar L, Siddiqi OK, Hammoud DA, Prasadarao NV, Sandor M, Hafner R, Fabry Z. NIH Tuberculous Meningitis Writing Group. Tuberculous meningitis: a roadmap for advancing basic and translational research. Nat Immunol. 2018;19(6):521–5. https://doi.org/10.1038/s41590-018-0119-x.
Article CAS PubMed PubMed Central Google Scholar
Ar R. The pathogenesis of tuberculous meningitis. Bull John Hopkins Hosp. 1933;52:5.
Leonard JM. Central nervous system tuberculosis. Microbiol Spectr. 2017;5(2). https://doi.org/10.1128/microbiolspec. A good review with detailed descriptions of the tuberculoma.
Zaharie S-D, et al. The immunological architecture of granulomatous inflammation in central nervous system tuberculosis. Tuberculosis. 2020;125:102016.
Tripathi S, et al. Glial alterations in tuberculous and cryptococcal meningitis and their relation to HIV co-infection – a study on human brains. J Infect Dev Ctries. 2014;8:1421–43.
Perez-Malagon CD, Barrera-Rodriguez R, Lopez-Gonzalez MA, Alva-Lopez LF. Diagnostic and neurological overview of brain tuberculomas: a review of literature. Cureus. 2021. https://doi.org/10.7759/cureus.20133.
Article PubMed PubMed Central Google Scholar
Anuradha HK, et al. Intracranial tuberculomas in patients with tuberculous meningitis: predictors and prognostic significance. Int J Tuberc Lung Dis. 2011;15(2):234–9.
Spanos JP, Hsu NJ, Jacobs M. Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis. Front Cell Neurosci. 2015;9:182. https://doi.org/10.3389/fncel.2015.00182.
Article CAS PubMed PubMed Central Google Scholar
Tan W, et al. Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase. Cell Discov. 2022;8:1–18.
Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18:225–42.
Verhoeven D. Immunometabolism and innate immunity in the context of immunological maturation and respiratory pathogens in young children. J Leukoc Biol. 2019;106:301–8.
Mylonas A, O’Loghlen A. cellular senescence and ageing: mechanisms and interventions. Front Aging. 2022;3:866718.
PubMed PubMed Central Google Scholar
Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123:958–65.
CAS PubMed PubMed Central Google Scholar
Lee J, Kim H-J. Normal aging induces changes in the brain and neurodegeneration progress: review of the structural, biochemical, metabolic, cellular, and molecular changes. Front Aging Neurosci. 2022;14:931536.
CAS PubMed PubMed Central Google Scholar
Malaeb S, Cohen S, Virgintino D, Stonestreet B. Core Concepts: Development of the Blood-Brain Barrier. NeoReviews. 2012;13:e241–50. https://doi.org/10.1542/neo.13-4-e241.
Knox EG, Aburto MR, Clarke G, Cryan JF, O’Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27(6):2659–73. https://doi.org/10.1038/s41380-022-01511-z.
Article CAS PubMed PubMed Central Google Scholar
Ducomble T, et al. The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill. 2013;18(12):20436.
Ngwa C, et al. Age and sex differences in primary microglia culture: a comparative study. J Neurosci Methods. 2021;364:109359.
PubMed PubMed Central Google Scholar
Nikodemova M, Small AL, Kimyon RS, Watters JJ. Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age. Physiol Genomics. 2016;48:336–44.
CAS PubMed PubMed Central Google Scholar
Letiembre M, et al. Innate immune receptor expression in normal brain aging. Neuroscience. 2007;146:248–54.
Xie Z, et al. By Regulating the NLRP3 inflammasome can reduce the release of inflammatory factors in the co-culture model of tuberculosis H37Ra strain and rat microglia. Front Cell Infect Microbiol. 2021;11:637769.
CAS PubMed PubMed Central Google Scholar
Yang CS, et al. Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia. J Neuroinflammation. 2007;4:27. https://doi.org/10.1186/1742-2094-4-27. This study reveals intracellular signaling involved in the pro-inflammatory response by Mtb-challenged microglia in vitro.
Curto M, et al. Inhibition of cytokines expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem Int. 2004;44:381–92.
留言 (0)